DoW Parkinson’s, Investigator-Initiated Research Award
Defense Health Agency Contracting Activity - DHACA
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 18, 2026
- Amount
- Program total $10M
- Closes
- Nov 6, 2026 (in 49 days)
Similar opportunities open now
- DoW Parkinson’s, Early Investigator Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 49 days
- DoW Bone Marrow Failure, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 47 days
- DoW Kidney Cancer, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 10 days
- DoW Breast Cancer, Clinical Research Extension AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 61 days
- DoW Spinal Cord Injury, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 55 days
Classification and identifiers
- Solicitation number
- HT942526PRPIIRA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $10M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Parkinson’s Research Program (PRP) Investigator-Initiated Research Award (IIRA) supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s disease research. Research must address at least one of the four FY26 PRP Focus Areas . Distinctive Features: · Partnering Principal Investigator (PI) Option: Allows for more than one PI. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The other PI(s) will be identified as Partnering PI(s), with a maximum of two Partnering PIs. · Preliminary data are required. · Clinical trials are allowed.